PO.2.35 Association between clinical manifestations and SLE-specific antibodies measured by a novel pmat technology in systemic lupus erythematosus
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-10-01
|
| Series: | Lupus Science and Medicine |
| _version_ | 1797996602410926080 |
|---|---|
| author | M Lopez-Hoyos M Mähler A Seaman C Andalucia J Irure-Ventura E González-López A Roa-Bautista E Aron MA Aure |
| author_facet | M Lopez-Hoyos M Mähler A Seaman C Andalucia J Irure-Ventura E González-López A Roa-Bautista E Aron MA Aure |
| author_sort | M Lopez-Hoyos |
| collection | DOAJ |
| first_indexed | 2024-04-11T10:19:54Z |
| format | Article |
| id | doaj.art-deba33b3d08d4805b01156fffa93e2da |
| institution | Directory Open Access Journal |
| issn | 2053-8790 |
| language | English |
| last_indexed | 2024-04-11T10:19:54Z |
| publishDate | 2022-10-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Lupus Science and Medicine |
| spelling | doaj.art-deba33b3d08d4805b01156fffa93e2da2022-12-22T04:29:48ZengBMJ Publishing GroupLupus Science and Medicine2053-87902022-10-019Suppl 210.1136/lupus-2022-elm2022.65PO.2.35 Association between clinical manifestations and SLE-specific antibodies measured by a novel pmat technology in systemic lupus erythematosusM Lopez-Hoyos0M Mähler1A Seaman2C Andalucia3J Irure-Ventura4E González-López5A Roa-Bautista6E Aron7MA Aure8Servicio de Inmunología, Hospital Universitario Marqués de Valdecilla, Facultad de Medicina, Universidad de Cantabria, Santander, SpainInstitute for Laboratory Animal Science and Central Animal Facility, Medical School Hannover, Hannover, Germany1Headquarters and Technology Center Autoimmunity, Werfen ~ San Diego ~ USA1Headquarters and Technology Center Autoimmunity, Werfen ~ San Diego ~ USA2Immunology Department, Hospital Universitario Marqués de Valdecilla-IDIVAL ~ Santander ~ Spain2Immunology Department, Hospital Universitario Marqués de Valdecilla-IDIVAL ~ Santander ~ Spain2Immunology Department, Hospital Universitario Marqués de Valdecilla-IDIVAL ~ Santander ~ Spain1Headquarters and Technology Center Autoimmunity, Werfen ~ San Diego ~ USA1Headquarters and Technology Center Autoimmunity, Werfen ~ San Diego ~ USA |
| spellingShingle | M Lopez-Hoyos M Mähler A Seaman C Andalucia J Irure-Ventura E González-López A Roa-Bautista E Aron MA Aure PO.2.35 Association between clinical manifestations and SLE-specific antibodies measured by a novel pmat technology in systemic lupus erythematosus Lupus Science and Medicine |
| title | PO.2.35 Association between clinical manifestations and SLE-specific antibodies measured by a novel pmat technology in systemic lupus erythematosus |
| title_full | PO.2.35 Association between clinical manifestations and SLE-specific antibodies measured by a novel pmat technology in systemic lupus erythematosus |
| title_fullStr | PO.2.35 Association between clinical manifestations and SLE-specific antibodies measured by a novel pmat technology in systemic lupus erythematosus |
| title_full_unstemmed | PO.2.35 Association between clinical manifestations and SLE-specific antibodies measured by a novel pmat technology in systemic lupus erythematosus |
| title_short | PO.2.35 Association between clinical manifestations and SLE-specific antibodies measured by a novel pmat technology in systemic lupus erythematosus |
| title_sort | po 2 35 association between clinical manifestations and sle specific antibodies measured by a novel pmat technology in systemic lupus erythematosus |
| work_keys_str_mv | AT mlopezhoyos po235associationbetweenclinicalmanifestationsandslespecificantibodiesmeasuredbyanovelpmattechnologyinsystemiclupuserythematosus AT mmahler po235associationbetweenclinicalmanifestationsandslespecificantibodiesmeasuredbyanovelpmattechnologyinsystemiclupuserythematosus AT aseaman po235associationbetweenclinicalmanifestationsandslespecificantibodiesmeasuredbyanovelpmattechnologyinsystemiclupuserythematosus AT candalucia po235associationbetweenclinicalmanifestationsandslespecificantibodiesmeasuredbyanovelpmattechnologyinsystemiclupuserythematosus AT jirureventura po235associationbetweenclinicalmanifestationsandslespecificantibodiesmeasuredbyanovelpmattechnologyinsystemiclupuserythematosus AT egonzalezlopez po235associationbetweenclinicalmanifestationsandslespecificantibodiesmeasuredbyanovelpmattechnologyinsystemiclupuserythematosus AT aroabautista po235associationbetweenclinicalmanifestationsandslespecificantibodiesmeasuredbyanovelpmattechnologyinsystemiclupuserythematosus AT earon po235associationbetweenclinicalmanifestationsandslespecificantibodiesmeasuredbyanovelpmattechnologyinsystemiclupuserythematosus AT maaure po235associationbetweenclinicalmanifestationsandslespecificantibodiesmeasuredbyanovelpmattechnologyinsystemiclupuserythematosus |